Patient demographics
|
Age (year; mean) |
64.7 |
Male gender (%) |
52.9 |
Race (%) |
White |
59.5 |
Black |
34.8 |
Other/unknown |
5.7 |
Patient clinical history (%)
|
Primary cause of renal failure |
Diabetes |
50.6 |
Hypertension |
28.6 |
Glomerulonephritis |
9.4 |
Other/unknown |
11.4 |
Duration of dialysis (years) |
3.3 |
Baseline inpatient days (mean) |
1.3 |
Hypertension |
96.4 |
Diabetes |
66.4 |
Peripheral vascular disease |
38.2 |
Angina pectoris |
7.3 |
Congestive heart failure |
62.0 |
Myocardial infarction |
13.8 |
Coronary artery bypass graft |
5.8 |
Percutaneous transluminal coronary angloplasty |
9.6 |
Anemia management prior to baseline
|
Hematocrit (%, mean) |
35.3 |
EPO dose (units/administration, mean) |
7,630 |
Iron use (%) |
64.1 |
Facility characteristics (%)
|
Geographic region |
Northeast (Networks 1–5) |
24.3 |
Southeast (Networks 6–8, 13, 14) |
37.5 |
Midwest (Networks 9–12) |
21.5 |
West (Networks 15–18) |
16.7 |
Dialysis facility chain group |
|
DaVita |
31.3 |
Fresenius |
32.7 |
DCI |
4.1 |
Small chains |
12.9 |
Nonchain |
19.0 |